Clinical Trial Update: Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease [Phase 3]

View source ↗

Summary

This document reports the withdrawal of a Phase 3 pilot trial evaluating resveratrol supplementation in patients with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Alzheimer Disease | Phase 3 | Status: WITHDRAWN